Pravin Khemani is a Neurology physician affiliated with Swedish Medical Center. OpenAlex indexes 63 publications with 898 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 17th Ave Ste 540
Seattle, WA 98122
Telephone
206-386-3880Registry record last updated 29 Jun 2018.
Clinical trials
- Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism
Sponsor: University of Texas Southwestern Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cala Health, Inc.Program year20251 payment
- MDD US Operations, LLCProgram year20251 payment
- Mirum Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
82%Neuromuscular Blocker81.9%Onabotulinumtoxina55%Abobotulinumtoxina45%Part B, office-administered≥32 patientsgamma-Aminobutyric Acid-ergic Agonist0.2%Baclofen100%Part D≥14 patientsNervous system
16.2%Aromatic Amino Acid Decarboxylation Inhibitor7.5%Carbidopa-Levodopa55%Rytary27%Carbidopa-Levodopa Er18%Crexont1%Part D<11 patientsMonoamine Oxidase Inhibitor1.3%Rasagiline Mesylate81%Selegiline Hcl19%Part D≥75 patients+ 16 more classes in this area
Cardiovascular
1.1%Beta blocker0.7%Propranolol Hcl64%Propranolol Hcl Er36%Part D≥38 patientsalpha-Adrenergic Agonist0.2%Midodrine Hcl100%Part D≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Underlying Tremor Improvement with Consistent Use of Transcutaneous Afferent Patterned Stimulation in Patients with Essential Tremor
Tremor and Other Hyperkinetic Movements
2026 - Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia
Annals of Clinical and Translational Neurology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Rod Oskouian, MD
Swedish Medical Center
Ralph Aye, MD
Swedish Medical Center
Kelly Paulson, MD, PhD
Swedish Medical Center
Christopher McGann, MD
Swedish Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”